Cite

HARVARD Citation

    Danhof, S. et al. (n.d.). 'Real‐life' experience of preapproval carfilzomib‐based therapy in myeloma – analysis of cardiac toxicity and predisposing factors. European journal of haematology. pp. 25-32. [Online]. 
  
Back to record